학술논문
The impact of Jak1/Jak2 inhibitor ruxolitinib on the spleen size and symptom burden in myeloproliferative diseases
Document Type
Article
Author
Source
In: UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi . (UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, 2016, 26(3):153-158)
Subject
Language
English
Turkish
Turkish
ISSN
1306133X